Switching Medicare Advantage (MA) plans is increasingly common among MA enrollees, especially those dually eligible for ...
The randomized controlled period (RCP) in the phase 3 MINT trial of inebilizumab for myasthenia gravis (MG) wasn't reported ...
CMS is withholding $9.8 billion in Texas Medicaid hospital funding tied to CHIRP, costing hospitals $27 million a day in a tax dispute.
From a health system perspective, Martyn suggested that broader formulary access to finerenone makes sense as long as patient ...
AJMC: Your study found that emphysema affecting at least 20% of the lung on CT was consistently associated with differences ...
Tozorakimab cut moderate/severe COPD exacerbations up to 34% in the phase 3 trials OBERON and TITANIA across smoking status ...
Patients with ≥5 impaired domains experienced markedly worse outcomes versus none, including >2-fold higher mortality and ...
John R. Hurst, MD, PhD, explains how BEAM-302 gene editing targets both lung and liver disease in alpha-1 antitrypsin ...
In addition, Godara noted that toxicity management for bispecific antibodies has evolved. While early use of these therapies ...
A separate poster, drawing on data from the National Institutes of Health's All of Us Research Program, found that women with ...
Concurrent guideline statements have increased classification ambiguity, strengthening arguments for phenotype-first ...
Allocation frameworks do not prohibit age but label 65-70 as higher risk and >70 as high risk, while scoring systems may favor older candidates due to greater waitlist mortality. Pediatric indications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results